Method of treating benign prostatic hypertrophy with aureofacin
    1.
    发明授权
    Method of treating benign prostatic hypertrophy with aureofacin 失效
    用氧氟沙星处理胆固醇预处理的方法

    公开(公告)号:US3920813A

    公开(公告)日:1975-11-18

    申请号:US41496873

    申请日:1973-11-12

    申请人: SCHMID LAB

    发明人: GORDON HARRY W

    IPC分类号: E02F9/22 A61K35/00

    CPC分类号: A61K31/70 E02F9/2275

    摘要: Orally administered compositions for treating prostatic hypertrophy are described herein, these compositions containing an effective dose of a pharmaceutical formulation comprising aureofacin a polyenic macrolide. Also, the method of treating prostatic hypertrophy with such compositions, is described herein.

    Spray dispenser and shield
    2.
    发明授权
    Spray dispenser and shield 失效
    喷雾分配​​器和保护膜

    公开(公告)号:US3841533A

    公开(公告)日:1974-10-15

    申请号:US30923272

    申请日:1972-11-24

    申请人: SCHMID LAB

    发明人: CARROLL A BEALL G

    摘要: A device for dispensing fluids into a predetermined location, such as the eye, including a nozzle and a shield in which the nozzle head has at least one rib and the shield has a complementary groove, or grooves which mate with the rib, or ribs to respectively place the shield on the nozzle with the proper orientation so that the fluid can be dispensed into the eye as the shield covers it and to cover the nozzle orifice by a closed portion of the shield when the device is to be stored or transported.

    摘要翻译: 用于将流体分配到诸如眼睛的预定位置(例如眼睛)的装置,包括喷嘴和屏蔽件,其中喷嘴头具有至少一个肋,并且屏蔽件具有互补的凹槽,或与肋配合的凹槽,或肋与肋 分别以正确的方向将屏蔽物放置在喷嘴上,使得当屏蔽物覆盖时可以将流体分配到眼睛中,并且当装置要被储存或运输时,通过屏蔽的封闭部分覆盖喷嘴孔口。

    Polyenic macrolide compositions and methods of use
    3.
    发明授权
    Polyenic macrolide compositions and methods of use 失效
    多烯大环内酯组合物及其使用方法

    公开(公告)号:US3891752A

    公开(公告)日:1975-06-24

    申请号:US8050970

    申请日:1970-10-13

    申请人: SCHMID LAB

    摘要: A method of increasing the overall effectiveness, including stability and gastrointestinal tolerability, of a polyenic macrolide, candicidin, is described which comprises orally administering the candicidin with an absorbent material. Compositions containing a candicidin and a suitable absorbent material preferably in beadlet form are described for use in treating various conditions including prostate hypertrophy, hypercholesterolemia and acne.

    摘要翻译: 描述了一种增加多聚大环内酯,可待菌素的总体有效性(包括稳定性和肠胃耐受性)的方法,其包括用吸收材料口服给予啶啶酸酯。 描述了含有水cand啶和合适的吸收性材料优选珠粒形式的组合物用于治疗包括前列腺肥大,高胆固醇血症和痤疮的各种病症。

    Intra-uterine contraceptive device
    4.
    发明授权
    Intra-uterine contraceptive device 失效
    子宫内避孕器

    公开(公告)号:US3881475A

    公开(公告)日:1975-05-06

    申请号:US22746572

    申请日:1972-02-18

    申请人: SCHMID LAB

    IPC分类号: A61F6/14 A61F5/46

    CPC分类号: A61F6/144

    摘要: An intra-uterine contraceptive device having a pair of loops extending in opposite directions from a common stem. Each loop has a free end. The character and thickness of the material forming the loops and the shape of the loops are such as to permit the loops to more readily conform to the walls of the uterine cavity of the patient and thereby be better retained.

    摘要翻译: 一种子宫内避孕装置,具有从公共茎向相反方向延伸的一对环。 每个循环都有一个自由端。 形成环的材料的特性和厚度以及环的形状使得环可以更容易地符合患者的子宫腔的壁并且由此更好地保持。

    Method of treating prostatic hypertrophy with levarin
    5.
    发明授权
    Method of treating prostatic hypertrophy with levarin 失效
    用LEVARIN治疗前列腺增生症的方法

    公开(公告)号:US3843785A

    公开(公告)日:1974-10-22

    申请号:US31356872

    申请日:1972-12-08

    申请人: SCHMID LAB

    发明人: GORDON H

    IPC分类号: A61K35/70

    CPC分类号: A61K31/70

    摘要: Orally administered compositions for treating prostatic hypertrophy are described herein, these compositions containing an effective dose of a pharmaceutical formulation comprising levarin, a polyenic macrolide. Also, the method of treating prostatic hypertrophy with such compositions, is described herein.

    Method for treating hypercholesterolemia
    6.
    发明授权
    Method for treating hypercholesterolemia 失效
    治疗高脂血症的方法

    公开(公告)号:US3855409A

    公开(公告)日:1974-12-17

    申请号:US17751271

    申请日:1971-09-02

    申请人: SCHMID LAB

    发明人: GORDON H SCHAFFNER C

    IPC分类号: A61K31/365 A61K31/335

    CPC分类号: A61K31/365

    摘要: Orally administered compositions for altering lipid metabolism are described herein, these compositions containing an effective dose of a pharmaceutical formulation having a molecular structure including a polyenic macrolide nucleus having at least five conjugated double bonds. Also the method of altering lipid metabolism including reducing and controlling the blood cholesterol level, is described herein.

    摘要翻译: 本文描述了用于改变脂质代谢的口服给药组合物,这些组合物含有有效剂量的具有分子结构的药物制剂,其包含具有至少五个共轭双键的多聚大环内酯核。 此外,本文描述了改变脂质代谢的方法,包括降低和控制血液胆固醇水平。